First test of new shot aims to tame hepatitis b
Disease control
Recruiting now
This is the first study in people to test the safety of a new drug called GIGA-2339 for chronic Hepatitis B. It will involve 48 participants who already have the infection. The main goal is to see if the drug is safe and how the body processes it when given through an IV at diffe…
Phase: PHASE1 • Sponsor: GigaGen, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC